• Home
  • About Us
    • AdAlta at a glance
    • Board
    • Management Team
  • Cancer Cell Therapies
    • “East to West” strategy
    • “East to West” product pipeline
  • I-Body Therapeutics
    • i-bodies
    • AD-214: A new approach to fibrotic disease
    • Fibrosis
  • Investors
    • Annual and Financial Reports
    • Presentations
    • Analyst Reports
    • ASX Announcements
    • News & Media
    • Corporate Governance
  • Contact Us

Appendix 4G and Corporate Governance Statement

Appendix 4G and Corporate Governance Statement

Archives

2018

..

2017

..

2016

..

2015

..

2014

..

2013

..

2012

..

2011

..
© 2025 AdAlta Limited Disclaimer | Privacy Policy
© 2016 AdAlta Limited